<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03534388</url>
  </required_header>
  <id_info>
    <org_study_id>CLN 004.2</org_study_id>
    <nct_id>NCT03534388</nct_id>
  </id_info>
  <brief_title>A Feasibility Study to Evaluate Skin Cleansing With a Sodium Hypochlorite Wash</brief_title>
  <official_title>A Feasibility Study to Evaluate a Skin Cleansing Regimen With a Sodium Hypochlorite Wash in Lower Extremity Arterial Bypass Graft Surgery or Femoral Endarterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TopMD Skin Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TopMD Skin Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility study in approximately 20 subjects to investigate the rate of infection with
      subjects undergoing elective lower extremity arterial bypass graft surgery or femoral
      endarterectomy. The subjects are instructed to shower with the sodium hypochlorite body wash
      daily, or as modified by the physician, for 5 of the 7 days leading to their surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a feasibility study in approximately 20 subjects over a 5-week period per subject.
      The study will investigate the rate of infection with subjects undergoing elective lower
      extremity arterial bypass graft surgery or femoral endarterectomy. The subjects are
      instructed to shower with the sodium hypochlorite body wash daily, or as modified by the
      physician, for 5 of the 7 days leading to their surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Feasibility comparing to retrospective data.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in percentage</measure>
    <time_frame>5 week per subject</time_frame>
    <description>Fewer infected patients than in the retrospective data</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Arterial Bypass Graft Surgery</condition>
  <arm_group>
    <arm_group_label>Prospective Subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sodium Hypochlorite Cleanser</intervention_name>
    <description>Cleansing with CLn BodyWash</description>
    <arm_group_label>Prospective Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is male or female greater than the age of 18 years.

          2. Subject is willing and able to give written informed consent and to comply with the
             requirements of the study.

          3. Subject has 5 or more days of time prior to elective surgery scheduled to sign consent
             and begin washing parameters.

          4. Subject is capable of taking a shower and lathering their entire body, or is able to
             be helped by a caregiver to shower each day with lather on their entire body for 5 out
             of 7 days immediately prior to elective surgery. (Modifications for bath usage can be
             made by the physician if the result of the product being left on the skin of the
             entire body for the time commitment is maintained, and if the body can be rinsed with
             poured water. Bed bath is not considered an allowable modification.)

        Exclusion Criteria:

          -  1) Subject is on antibiotics prior to surgery.

             2) Subject is unable to maintain washing regimen for the full study term.

             3) Subject is unable to follow pre-surgery cleansing instructions for 5 of the 7 days
             immediately prior to surgery. (Bed bath is not considered a cleansing day.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen E Hohmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Vascular Associates</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shari Anwar</last_name>
    <phone>2147042169</phone>
    <email>sanwar@clnwash.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Texas Vascular Associates, PA</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Moore, NP</last_name>
      <phone>214-821-9600</phone>
      <email>ashleym@tx-vascular.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2017</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sodium Hypochlorite</mesh_term>
    <mesh_term>Eusol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

